DFB Pharmaceuticals, a Fort Worth, Texas-based private investment group with an entrepreneurial drive for developing new products and businesses in healthcare, announced the promotion of Colin Marr to President of Phyton Ltd.
Phyton Biotech Wins Grant to Develop New Approaches to Manufacturing Artemisinin Bill & Melinda Gates Foundation Invests in R&D Pilot for Anti-Malarial Active Pharmaceutical Ingredients AHRENSBURG, Germany, November 29, 2017 – Phyton Biotech today announced that it has received a $400,000 grant from the Bill & [...]
Phyton Biotech showcased plant cell fermentation at CPhI Worldwide NOVEMBER 9, 2017 This October, Phyton Biotech attended CPhI Worldwide to exhibit its capabilities and the wide range of applications for the company’s proprietary Plant Cell Fermentation Technology (PCF®). CPhI Worldwide is the largest pharmaceutical industry trade [...]
Case Study: Green Chemistry Phyton Biotech develops and applies sustainable “green technology” manufacturing solutions for phytochemicals through its award-winning and proprietary Plant Cell Fermentation (PCF®) process. The impact of this revolutionary technology is exemplified by Phyton’s environmentally responsible paclitaxel manufacturing process. Summary of Problem: [...]
Taxol® (manufactured by Bristol-Myers Squibb) is an important drug used to treat many types of solid tumor cancers and Kaposi’s sarcoma. It is on the World Health Organization’s List of Essential Medicines, the most needed medicines in a health care system.
Phyton Biotech Achieves Manufacturing Milestone with Thapsigargin, the Active Agent in Mipsagargin AHRENSBURG, Germany--(BUSINESS WIRE)--Phyton Biotech today announced that it has achieved a major milestone in connection with the manufacture of thapsigargin, an inhibitor derived from the Thapsia plant that is the active agent for the investigational [...]
Patent Application for GenSpera Partner Phyton Biotech Is Published by World Intellectual Property Organization (WIPO)
Patent Application for GenSpera Partner Phyton Biotech Is Published by World Intellectual Property Organization (WIPO) Production of Thapsigargins by Thapsia Cell Suspension Culture" Filed by Phyton Biotech SAN ANTONIO, TX--(Marketwired - Jul 13, 2015) - GenSpera, Inc. (OTCQB: GNSZ) today announced that its strategic partner Phyton [...]
GenSpera Announces Partnership With Global Supplier Company to Partner with Phyton Biotech for Manufacture of the Key Ingredient in Mipsagargin SAN ANTONIO, Feb. 9, 2015 -- GenSpera, Inc. (OTCQB: GNSZ) today announced a strategic partnership with Phyton Biotech for the manufacture of thapsigargin, which is derived from [...]
Phyton Biotech Receives CEP for Docetaxel API VANCOUVER, Canada--Phyton Biotech, a global supplier of high-quality paclitaxel and docetaxel API, has been granted a Certificate of suitability to European Pharmacopeia (CEP) by the European Directorate for the Quality of Medicines and HealthCare (EDQM) for its docetaxel anhydrous active [...]
Phyton Biotech Receives CEP for Paclitaxel API Produced by Plant Cell Fermentation VANCOUVER, British Columbia--Phyton Biotech, a global supplier of high-quality paclitaxel and docetaxel API, has been granted a Certificate of suitability to European Pharmacopeia (CEP) by the European Directorate for the Quality of Medicines and HealthCare (EDQM) [...]